Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26


NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.

de Graaf KL, Lapeyre G, Guilhot F, Ferlin W, Curbishley SM, Carbone M, Richardson P, Moreea S, McCune CA, Ryder SD, Chapman RW, Floreani A, Jones DE, de Min C, Adams DH, Invernizzi P.

Hepatol Commun. 2018 Mar 23;2(5):492-503. doi: 10.1002/hep4.1170. eCollection 2018 May.


Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.

Foster GR, Agarwal K, Cramp ME, Moreea S, Barclay S, Collier J, Brown AS, Ryder SD, Ustianowski A, Forton DM, Fox R, Gordon F, Rosenberg WM, Mutimer DJ, Du J, Gilbert CL, Asante-Appiah E, Wahl J, Robertson MN, Barr E, Haber B.

Hepatology. 2018 Feb 23. doi: 10.1002/hep.29852. [Epub ahead of print]


Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank.

McLauchlan J, Innes H, Dillon JF, Foster G, Holtham E, McDonald S, Wilkes B, Hutchinson SJ, Irving WL; HCV Research UK Steering Committee.

Int J Epidemiol. 2017 Oct 1;46(5):1391-1391h. doi: 10.1093/ije/dyw362. No abstract available.


Duodenal variceal bleed: an unusual cause of upper gastrointestinal bleed and a difficult diagnosis to make.

Bhagani S, Winters C, Moreea S.

BMJ Case Rep. 2017 Feb 27;2017. pii: bcr2016218669. doi: 10.1136/bcr-2016-218669.


Erratum to: 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.

Lau MS, Mooney PD, White WL, Appleby V, Moreea S, Haythem I, Elias JE, Bundhoo K, Corbett GD, Wong L, Tsai HH, Cross SS, Hebden JM, Hoque S, Sanders DS.

BMC Gastroenterol. 2016 Oct 5;16(1):122. No abstract available.


'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.

Lau MS, Mooney P, White W, Appleby V, Moreea S, Haythem I, Elias J, Bundhoo K, Corbett G, Wong L, Tsai HH, Cross S, Hebden J, Hoque S, Sanders D.

BMC Gastroenterol. 2016 Sep 15;16:115. doi: 10.1186/s12876-016-0521-5. Erratum in: BMC Gastroenterol. 2016 Oct 5;16(1):122.


Prednisolone or pentoxifylline for alcoholic hepatitis.

Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, Downs N, Gleeson D, MacGilchrist A, Grant A, Hood S, Masson S, McCune A, Mellor J, O'Grady J, Patch D, Ratcliffe I, Roderick P, Stanton L, Vergis N, Wright M, Ryder S, Forrest EH; STOPAH Trial.

N Engl J Med. 2015 Apr 23;372(17):1619-28. doi: 10.1056/NEJMoa1412278.


Use of the haemostatic agent TC-325 in the treatment of bleeding secondary to endoscopic retrograde cholangiopancreatography sphincterotomy.

Appleby VJ, Hutchinson JM, Beckett CJ, Moreea S.

QJM. 2015 Jan;108(1):79-80. doi: 10.1093/qjmed/hcu135. Epub 2014 Jul 1. No abstract available.


Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial.

Shoeb D, Dearden J, Weatherall A, Bargery C, Moreea S, Alam S, White E, Vila X, Freshwater D, Ryder S, Mills PR, Alexander GJ, Forton D, Foster GR.

J Hepatol. 2014 Apr;60(4):699-705. doi: 10.1016/j.jhep.2013.11.011. Epub 2013 Nov 26.


Modern management of acute non-variceal upper gastrointestinal bleeding.

Hegade VS, Sood R, Mohammed N, Moreea S.

Postgrad Med J. 2013 Oct;89(1056):591-8. doi: 10.1136/postgradmedj-2013-131842. Epub 2013 Aug 7. Review.


Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-two case reports.

Hegade VS, Sood R, Saralaya D, Moreea S.

Ann Hepatol. 2013 Jul-Aug;12(4):629-33.


Investigation and management of functional dyspepsia.

Sood R, Mohammed N, Hegade VS, Moreea S.

Br J Hosp Med (Lond). 2013 Apr;74(4):208-11. Review. No abstract available.


The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort.

Pells G, Mells GF, Carbone M, Newton JL, Bathgate AJ, Burroughs AK, Heneghan MA, Neuberger JM, Day DB, Ducker SJ; UK-PBC Consortium, Sandford RN, Alexander GJ, Jones DE.

J Hepatol. 2013 Jul;59(1):67-73. doi: 10.1016/j.jhep.2013.02.019. Epub 2013 Mar 4.


Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.

Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, Neuberger JM, Day DB, Ducker SJ; UK PBC Consortium, Sandford RN, Alexander GJ, Jones DE.

Gastroenterology. 2013 Mar;144(3):560-569.e7; quiz e13-4. doi: 10.1053/j.gastro.2012.12.005. Epub 2012 Dec 12.


The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.

Tedder RS, Rodger AJ, Fries L, Ijaz S, Thursz M, Rosenberg W, Naoumov N, Banatvala J, Williams R, Dusheiko G, Chokshi S, Wong T, Rosenberg G, Moreea S, Bassendine M, Jacobs M, Mills PR, Mutimer D, Ryder SD, Bathgate A, Hussaini H, Dillon JF, Wright M, Bird G, Collier J, Anderson M, Johnson AM; Collaborative UK Study of Chronic Hepatitis B Infection (CUSHI-B) Study Group.

Clin Infect Dis. 2013 Apr;56(7):951-60. doi: 10.1093/cid/cis1013. Epub 2012 Dec 7.


The 4-hour rule: preventing crowding in the emergency department.

Hegade VS, Sood R, Moreea S.

Ann Emerg Med. 2012 Jul;60(1):133; author reply 133-4. doi: 10.1016/j.annemergmed.2011.12.028. No abstract available.


Response to clopidogrel with proton pump inhibitors: safe or not?

Ulhaq I, Sood R, Hegade V, Moreea S, Bulugahapitiya S.

Clin Cardiol. 2011 Nov;34(11):721; author reply 721. doi: 10.1002/clc.20978. Epub 2011 Oct 13. No abstract available.


Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapse.

Shoeb D, Rowe IA, Freshwater D, Mutimer D, Brown A, Moreea S, Sood R, Marley R, Sabin CA, Foster GR.

Eur J Gastroenterol Hepatol. 2011 Sep;23(9):747-53. doi: 10.1097/MEG.0b013e3283488aba.


Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin.

Uddin G, Shoeb D, Solaiman S, Marley R, Gore C, Ramsay M, Harris R, Ushiro-Lumb I, Moreea S, Alam S, Thomas HC, Khan S, Watt B, Pugh RN, Ramaiah S, Jervis R, Hughes A, Singhal S, Cameron S, Carman WF, Foster GR.

J Viral Hepat. 2010 May;17(5):327-35. doi: 10.1111/j.1365-2893.2009.01240.x. Epub 2009 Dec 9.


Supplemental Content

Loading ...
Support Center